Header Logo

Shivanjali Shankaran

Concepts (58)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
5
2023
439
1.060
Why?
Pre-Exposure Prophylaxis
1
2022
5
0.730
Why?
Anti-HIV Agents
1
2022
63
0.700
Why?
Klebsiella Infections
1
2016
64
0.470
Why?
Drug Resistance, Multiple, Bacterial
1
2016
68
0.460
Why?
Klebsiella pneumoniae
1
2016
70
0.460
Why?
Bacterial Proteins
1
2016
89
0.460
Why?
beta-Lactamases
1
2016
94
0.460
Why?
Sexual and Gender Minorities
2
2023
23
0.380
Why?
Electronic Health Records
2
2022
64
0.320
Why?
Sexually Transmitted Diseases
1
2023
12
0.200
Why?
Hepatitis C
1
2023
42
0.190
Why?
HIV-1
1
2022
203
0.170
Why?
Cross Infection
1
2023
295
0.170
Why?
Anti-Bacterial Agents
3
2023
363
0.160
Why?
Humans
10
2023
23175
0.160
Why?
Female
5
2023
13131
0.150
Why?
Adolescent
3
2022
1884
0.140
Why?
Mass Screening
1
2019
162
0.140
Why?
Colistin
1
2016
3
0.120
Why?
Minocycline
1
2016
5
0.120
Why?
Retrospective Studies
2
2023
2990
0.100
Why?
Male
5
2023
12648
0.100
Why?
Homosexuality, Male
2
2023
25
0.100
Why?
Adult
3
2022
6949
0.090
Why?
HIV Antigens
2
2022
12
0.090
Why?
HIV Antibodies
2
2022
14
0.090
Why?
Vibrio
1
2011
1
0.090
Why?
Vibrio Infections
1
2011
1
0.090
Why?
Skin Diseases, Bacterial
1
2011
1
0.090
Why?
Foodborne Diseases
1
2011
2
0.090
Why?
Seafood
1
2011
9
0.090
Why?
Young Adult
1
2016
1656
0.080
Why?
Influenza A Virus, H1N1 Subtype
1
2010
17
0.080
Why?
Bacteremia
1
2011
98
0.080
Why?
Chemotherapy, Adjuvant
1
2010
80
0.080
Why?
Influenza, Human
1
2010
40
0.080
Why?
Disease Outbreaks
1
2010
76
0.080
Why?
Middle Aged
3
2019
7970
0.080
Why?
Antiviral Agents
1
2010
66
0.080
Why?
Chicago
2
2023
847
0.070
Why?
Aged, 80 and over
1
2016
3864
0.070
Why?
Aged
1
2016
7650
0.050
Why?
HIV-2
1
2022
8
0.050
Why?
Immunoassay
1
2022
33
0.050
Why?
Inpatients
1
2023
113
0.050
Why?
Minority Groups
1
2022
70
0.050
Why?
Population Surveillance
1
2022
105
0.050
Why?
Sensitivity and Specificity
1
2022
445
0.040
Why?
Program Development
1
2019
44
0.040
Why?
Program Evaluation
1
2019
103
0.040
Why?
Urban Population
1
2019
131
0.040
Why?
Pandemics
1
2020
207
0.030
Why?
United States
1
2022
1801
0.030
Why?
Emergency Service, Hospital
1
2019
253
0.030
Why?
Fluoroquinolones
1
2011
12
0.020
Why?
Skin
1
2011
117
0.020
Why?
Treatment Outcome
1
2011
2943
0.010
Why?
Shankaran's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (58)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_